111, Inc. Sponsored ADR (NASDAQ:YI - Get Free Report)'s share price shot up 3.2% during mid-day trading on Monday . The stock traded as high as $7.25 and last traded at $6.79. 10,261 shares changed hands during mid-day trading, a decline of 4% from the average session volume of 10,742 shares. The stock had previously closed at $6.58.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a "sell (e+)" rating on shares of 111 in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of "Sell".
Read Our Latest Analysis on 111
111 Stock Up 3.2%
The firm has a market cap of $58.67 million, a P/E ratio of -6.79 and a beta of 0.69. The firm's fifty day moving average is $7.17 and its two-hundred day moving average is $5.22.
111 Company Profile
(
Get Free Report)
111, Inc NASDAQ: YI is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc's product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider 111, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list.
While 111 currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
